Pentostatin, cyclophosphamide and rituximab is a safe and effective treatment in patients with Waldenström’s macroglobulinemia
Waldenström’s macroglobulinemia (WM) is an indolent lym phomaand is responsive to therapy regimens containing alkylating agents, purine analogs and rituximab if treatment becomes necessary. We initiated a multicenter phase II trial to determine the safety and efficacy of a regimen containing pentos...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2015
|
| In: |
Leukemia and lymphoma
Year: 2014, Jahrgang: 56, Heft: 1, Pages: 97-102 |
| ISSN: | 1029-2403 |
| DOI: | 10.3109/10428194.2014.911869 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3109/10428194.2014.911869
|
| Verfasserangaben: | Isabelle Herth, Manfred Hensel, Michael Rieger, Kristin Horstmann, Wolfgang Hiddemann, Martin Dreyling, Silvia Koniczek, Mathias Witzens-Harig, Anthony D. Ho |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1728045622 | ||
| 003 | DE-627 | ||
| 005 | 20220818185235.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200831r20152014xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3109/10428194.2014.911869 |2 doi | |
| 035 | |a (DE-627)1728045622 | ||
| 035 | |a (DE-599)KXP1728045622 | ||
| 035 | |a (OCoLC)1341358085 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Krämer, Isabelle |d 1984- |e VerfasserIn |0 (DE-588)1025613481 |0 (DE-627)723627738 |0 (DE-576)370555724 |4 aut | |
| 245 | 1 | 0 | |a Pentostatin, cyclophosphamide and rituximab is a safe and effective treatment in patients with Waldenström’s macroglobulinemia |c Isabelle Herth, Manfred Hensel, Michael Rieger, Kristin Horstmann, Wolfgang Hiddemann, Martin Dreyling, Silvia Koniczek, Mathias Witzens-Harig, Anthony D. Ho |
| 264 | 1 | |c 2015 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published online: 25 Jun 2014 | ||
| 500 | |a Gesehen am 31.08.2020 | ||
| 520 | |a Waldenström’s macroglobulinemia (WM) is an indolent lym phomaand is responsive to therapy regimens containing alkylating agents, purine analogs and rituximab if treatment becomes necessary. We initiated a multicenter phase II trial to determine the safety and efficacy of a regimen containing pentostatin, cyclophosphamide and rituximab (PER) in patients with WM. Between May 2005 and December 2010, 25 patients with WM were included in the study. Twenty-one patients received PER as first-line therapy. In these patients, 2-year progression-free survival was 83.6% and 2-year overall survival was 100%. Thirteen patients (52%) received R maintenance therapy. In these patients, the 2-year progression-free survival was 91.67% and 2-year overall survival was 100%. We have provided evidence that PER is a safe and effective regimen for WM. Although R maintenance therapy after PER seemed to induce a better long-term outcome, this study was not powered to address this issue. | ||
| 534 | |c 2014 | ||
| 650 | 4 | |a cyclophosphamide | |
| 650 | 4 | |a maintenance therapy | |
| 650 | 4 | |a pentostatin | |
| 650 | 4 | |a rituximab | |
| 650 | 4 | |a Waldenström macroglobulinemia | |
| 700 | 1 | |a Hensel, Manfred |d 1964- |e VerfasserIn |0 (DE-588)1065849729 |0 (DE-627)816878307 |0 (DE-576)425541908 |4 aut | |
| 700 | 1 | |a Rieger, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Horstmann, Kristin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hiddemann, Wolfgang |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dreyling, Martin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Koniczek, Silvia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Witzens-Harig, Mathias |e VerfasserIn |0 (DE-588)1050736516 |0 (DE-627)784812322 |0 (DE-576)404988970 |4 aut | |
| 700 | 1 | |a Ho, Anthony Dick |d 1948- |e VerfasserIn |0 (DE-588)108692477 |0 (DE-627)504904205 |0 (DE-576)19010466X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia and lymphoma |d London [u.a.] : Taylor & Francis Group, 1989 |g 56(2015), 1, Seite 97-102 |h Online-Ressource |w (DE-627)324746237 |w (DE-600)2030637-4 |w (DE-576)099718170 |x 1029-2403 |7 nnas |a Pentostatin, cyclophosphamide and rituximab is a safe and effective treatment in patients with Waldenström’s macroglobulinemia |
| 773 | 1 | 8 | |g volume:56 |g year:2015 |g number:1 |g pages:97-102 |g extent:6 |a Pentostatin, cyclophosphamide and rituximab is a safe and effective treatment in patients with Waldenström’s macroglobulinemia |
| 856 | 4 | 0 | |u https://doi.org/10.3109/10428194.2014.911869 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200831 | ||
| 993 | |a Article | ||
| 994 | |a 2015 | ||
| 998 | |g 108692477 |a Ho, Anthony Dick |m 108692477:Ho, Anthony Dick |d 910000 |d 910100 |e 910000PH108692477 |e 910100PH108692477 |k 0/910000/ |k 1/910000/910100/ |p 9 |y j | ||
| 998 | |g 1050736516 |a Witzens-Harig, Mathias |m 1050736516:Witzens-Harig, Mathias |d 910000 |d 910100 |e 910000PW1050736516 |e 910100PW1050736516 |k 0/910000/ |k 1/910000/910100/ |p 8 | ||
| 998 | |g 1065849729 |a Hensel, Manfred |m 1065849729:Hensel, Manfred |d 50000 |e 50000PH1065849729 |k 0/50000/ |p 2 | ||
| 998 | |g 1025613481 |a Krämer, Isabelle |m 1025613481:Krämer, Isabelle |d 910000 |d 910100 |e 910000PK1025613481 |e 910100PK1025613481 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1728045622 |e 3744563146 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"display":"Krämer, Isabelle","roleDisplay":"VerfasserIn","role":"aut","family":"Krämer","given":"Isabelle"},{"roleDisplay":"VerfasserIn","display":"Hensel, Manfred","role":"aut","family":"Hensel","given":"Manfred"},{"roleDisplay":"VerfasserIn","display":"Rieger, Michael","role":"aut","family":"Rieger","given":"Michael"},{"given":"Kristin","family":"Horstmann","role":"aut","display":"Horstmann, Kristin","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","display":"Hiddemann, Wolfgang","role":"aut","family":"Hiddemann","given":"Wolfgang"},{"family":"Dreyling","given":"Martin","display":"Dreyling, Martin","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Silvia","family":"Koniczek","role":"aut","display":"Koniczek, Silvia","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","display":"Witzens-Harig, Mathias","role":"aut","family":"Witzens-Harig","given":"Mathias"},{"given":"Anthony Dick","family":"Ho","role":"aut","roleDisplay":"VerfasserIn","display":"Ho, Anthony Dick"}],"title":[{"title":"Pentostatin, cyclophosphamide and rituximab is a safe and effective treatment in patients with Waldenström’s macroglobulinemia","title_sort":"Pentostatin, cyclophosphamide and rituximab is a safe and effective treatment in patients with Waldenström’s macroglobulinemia"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Published online: 25 Jun 2014","Gesehen am 31.08.2020"],"recId":"1728045622","language":["eng"],"name":{"displayForm":["Isabelle Herth, Manfred Hensel, Michael Rieger, Kristin Horstmann, Wolfgang Hiddemann, Martin Dreyling, Silvia Koniczek, Mathias Witzens-Harig, Anthony D. Ho"]},"origin":[{"dateIssuedDisp":"2015","dateIssuedKey":"2015"}],"id":{"eki":["1728045622"],"doi":["10.3109/10428194.2014.911869"]},"physDesc":[{"extent":"6 S."}],"relHost":[{"id":{"issn":["1029-2403"],"eki":["324746237"],"zdb":["2030637-4"]},"origin":[{"publisherPlace":"London [u.a.] ; London [u.a.]","publisher":"Taylor & Francis Group ; Informa Healthcare","dateIssuedKey":"1989","dateIssuedDisp":"1989-"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Leukemia and lymphoma","title":"Leukemia and lymphoma"}],"part":{"issue":"1","pages":"97-102","year":"2015","extent":"6","text":"56(2015), 1, Seite 97-102","volume":"56"},"pubHistory":["1.1989/90 -"],"recId":"324746237","language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Pentostatin, cyclophosphamide and rituximab is a safe and effective treatment in patients with Waldenström’s macroglobulinemiaLeukemia and lymphoma","note":["Gesehen am 08.09.15"]}]} | ||
| SRT | |a KRAEMERISAPENTOSTATI2015 | ||